Are you suggesting they shouldn’t manufacture more?
Once demand is met, there starts to be an argument for lowering the price and growing the market. Getting the price down to half the current price is when we start to see health benefits that outweigh the cost of treatment and an obvious win for insurance companies to start covering it for everyone.
But until there is supply, lowering cost just means more people fighting over the same supply, not more people getting access.